1999
DOI: 10.1016/s0091-3057(99)00072-6
|View full text |Cite
|
Sign up to set email alerts
|

Behavioral Effects of Flibanserin (BIMT 17)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
19
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(21 citation statements)
references
References 62 publications
2
19
0
Order By: Relevance
“…Flibanserin doses of 1–10 mg/kg IP produced a dose-and time-dependent depression of ICSS in this study, and these findings agree with previous reports that flibanserin displays similar potency to decrease rates of various other behaviors in rodents [6, 44]. For example, flibanserin doses of 8–16 mg/kg (IP) or 45 mg/kg (PO), which produced similar plasma flibanserin levels, decreased measures of spontaneous locomotion in female and male rats [6, 44].…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Flibanserin doses of 1–10 mg/kg IP produced a dose-and time-dependent depression of ICSS in this study, and these findings agree with previous reports that flibanserin displays similar potency to decrease rates of various other behaviors in rodents [6, 44]. For example, flibanserin doses of 8–16 mg/kg (IP) or 45 mg/kg (PO), which produced similar plasma flibanserin levels, decreased measures of spontaneous locomotion in female and male rats [6, 44].…”
Section: Discussionsupporting
confidence: 93%
“…The present results are not likely to reflect evaluation of an inadequate flibanserin dose range, because flibanserin was tested across a 10-fold dose range from low doses that produced no effect to high doses that only depressed ICSS, and flibanserin doses tested here also produce a range of other behavioral effects in rats (e.g. [43, 44]). Moreover, previous pharmacokinetic studies suggest that the flibanserin doses tested here would be associated with plasma levels spanning levels produced in humans by the recommended therapeutic dose of 100 mg PO [34, 43].…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…at stressful situations [11]. This may be reflected in the dose-dependent effect of 5-HT1A agonist on anxiety measured in unconditioned anxiety tests: low doses of were anxiolytic, while high doses were anxiogenic [1,7,19]. Low doses may result in different 5-HT release pattern and extracellular level and consequently different activation of 5-HT receptor subsets which is manifested in decreased anxiety [17,27].…”
Section: The Effect Of Buspironementioning
confidence: 99%
“…As each receptor does not have the same affinity to certain odorous substances, different concentrations of the same substance would activate various neuronal pathways differently [23]. Various endogenous factors such as hormones, cytokines, and neurotransmitters are supposed to be involved in the stress-induced hyperthermia [12,15,21,22], and actually the administration of certain drugs (e.g., adrenaline-beta antagonists, 5-HT1A or 2A receptor antagonists, NOS inhibitors or prostaglandin synthesis blockers) have been reported to suppress this stress-induced hyperthermia [2,10,14,18]. Why the concentration-effect of alphapinene was exerted differently among autonomic parameters has not bee determined, though one possible explanation appears to be based on this hypothesis regarding differing thresholds among neural pathways to a given odor.…”
mentioning
confidence: 99%